Autophagy sustains mitochondrial respiration and determines resistance to BRAF inhibition in thyroid carcinoma cells.

BRAF is the most prevalent mutation in thyroid cancer and correlates with poor prognosis and therapy resistance. Although selective inhibitors of BRAF have been developed, more advanced tumors such as anaplastic thyroid carcinomas show a poor response in clinical trials. Therefore, the study of alternative survival mechanisms is needed.